High platelet reactivity is associated with vascular function in patients after percutaneous coronary intervention receiving clopidogrel

International Journal of Cardiology

Volumn 177, Issue 1, 2014, Pages 192-196

  Siasos, Gerasimos ^a   Oikonomou, Evangelos ^a   Zaromitidou, Marina ^a   Kioufis, Stamatios ^a   Vavuranakis, Manolis ^a   Maniatis, Konstantinos ^a   Kokkou, Eleni ^a   Papageorgiou, Nikolaos ^a   Papaioannou, Spyridon ^a   Tourikis, Panagiotis ^a   Papavassiliou, Athanasios G ^a   Stefanadis, Christodoulos ^a   Tousoulis, Dimitris ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Clopidogrel; Coronary artery disease; Platelet reactivity; Vascular function

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ADULT; ANTICOAGULANT THERAPY; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; CARDIOVASCULAR FUNCTION; CAROTID FEMORAL PULSE WAVE VELOCITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG RESPONSE; FEMALE; FOLLOW UP; HEART FUNCTION TEST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PULSE WAVE; RISK ASSESSMENT; RISK FACTOR; ANALOGS AND DERIVATIVES; BLOOD; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; THROMBOCYTE; THROMBOCYTE AGGREGATION;

BLOOD PLATELETS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TICLOPIDINE;

EID: 84909953245     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.09.030     Document Type: Article

References (34)

1. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
2. S.C. Beinart, P. Kolm, E. Veledar, Z. Zhang, E.M. Mahoney, and O. Bouin Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial J Am Coll Cardiol 46 2005 761 769
3. T. Heitzer, V. Rudolph, E. Schwedhelm, M. Karstens, K. Sydow, and M. Ortak Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects Arterioscler Thromb Vasc Biol 26 2006 1648 1652
4. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, F. Alfonso, C. Macaya, and T.A. Bass Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives J Am Coll Cardiol 49 2007 1505 1516
5. C. Antoniades, D. Tousoulis, C. Vasiliadou, C. Pitsavos, K. Marinou, and E. Stefanadi Genetic polymorphism on eNOS gene modifies the smoking-associated risk for myocardial infarction in young individuals: a gene-environment interaction Eur Heart J 28 2007 585 586
6. C. Antoniades, D. Tousoulis, C. Vasiliadou, K. Marinou, C. Tentolouris, and G. Latsios Genetic polymorphism C807T but not A1648G on platelet glycoprotein Ia, increases the risk of premature myocardial infarction by modifying platelet activation in the presence of endothelial dysfunction Eur Heart J 28 2007 566
7. S. Laurent, J. Cockcroft, L. Van Bortel, P. Boutouyrie, C. Giannattasio, and D. Hayoz Expert consensus document on arterial stiffness: methodological issues and clinical applications Eur Heart J 27 2006 2588 2605
8. A.J. SLaC Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2
9. M.W. Rajzer, W. Wojciechowska, M. Klocek, I. Palka, M. Brzozowska-Kiszka, and K. Kawecka-Jaszcz Comparison of aortic pulse wave velocity measured by three techniques: Complior, SphygmoCor and Arteriograph J Hypertens 26 2008 2001 2007
10. R. Kelly, C. Hayward, A. Avolio, and M. O'Rourke Noninvasive determination of age-related changes in the human arterial pulse Circulation 80 1989 1652 1659
11. G. Campo, G. Parrinello, P. Ferraresi, B. Lunghi, M. Tebaldi, and M. Miccoli Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome J Am Coll Cardiol 57 2011 2474 2483
12. N.J. Breet, J.W. van Werkum, H.J. Bouman, J.C. Kelder, H.J. Ruven, and E.T. Bal Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
13. N. von Beckerath, G. Pogatsa-Murray, A. Wieczorek, D. Sibbing, A. Schomig, and A. Kastrati Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness Thromb Haemost 95 2006 910 911
14. F. Yamasaki, T. Furuno, K. Sato, D. Zhang, M. Nishinaga, and T. Sato Association between arterial stiffness and platelet activation J Hum Hypertens 19 2005 527 533
15. R.T. Wang, Y. Li, X.Y. Zhu, and Y.N. Zhang Increased mean platelet volume is associated with arterial stiffness Platelets 22 2011 447 451
16. H. Koyama, T. Maeno, S. Fukumoto, T. Shoji, T. Yamane, and H. Yokoyama Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans Circulation 108 2003 524 529
17. D. Chatzis, C. Tsioufis, P. Pavlidis, E. Taxiarchou, D. Tsiachris, and D. Tousoulis Brain natriuretic peptide and early cardiovascular adaptations in essential hypertension Eur Heart J 28 2007 242
18. K. Dimitriadis, C. Tsioufis, D. Tsiachris, I. Skiadas, E. Taxiarchou, and P. Missovoulos Urinary albumin excretion and cardiac structural adaptations in essential hypertensive subjects: correlations from the Hippokration Hellenic Hypertension (3H) study Eur Heart J 28 2007 242 243
19. A. Kakkavas, C. Tsioufis, D. Tsiachris, K. Dimitriadis, C. Thomopoulos, and D. Tousoulis Erectile dysfunction and microalbuminuria in essential hypertension: evidence for two interrelated pathologies of the vasculature Eur Heart J 28 2007 248
20. C. Thomopoulos, C. Tsioufis, K. Dimitriadis, A. Amfilochiou, D. Tousoulis, and P. Toutouzas Integrative approach to unmask sub-clinical target organ damage in hypertensives with obstructive sleep apnea: upper airway and kidneys mirror heart and vessels Eur Heart J 28 2007 248
21. G. Siasos, D. Tousoulis, and C. Stefanadis CYP2C19 genotype and cardiovascular events JAMA 307 2012 1483 1484 [author reply 1484-1485]
22. P.A. Gurbel, U.S. Tantry, A.R. Shuldiner, and D.J. Kereiakes Genotyping: one piece of the puzzle to personalize antiplatelet therapy J Am Coll Cardiol 56 2010 112 116
23. K. Aznaouridis, C. Vlachopoulos, A. Dagre, C. Masoura, C. Vasiliadou, and J. Skoumas Atorvastatin preserves endothelium-dependent vasomotion and NO bioavailability after an acute inflammatory stimulus Eur Heart J 28 2007 485
24. V.J. Dzau, and G.H. Gibbons Vascular remodeling: mechanisms and implications J Cardiovasc Pharmacol 21 Suppl. 1 1993 S1 S5
25. C. Vasiliadou, C. Antoniades, A. Axeimastos, D. Tousoulis, D. Kardara, and I. Dima Genetic polymorphism C242T on the p22-phox subunit of NADPH oxidase, modifies the risk for myocardial infarction in young individuals, by affecting platelets activation Eur Heart J 28 2007 280
26. A. Hermann, B.H. Rauch, M. Braun, K. Schror, and A.A. Weber Platelet CD40 ligand (CD40L)-subcellular localization, regulation of expression, and inhibition by clopidogrel Platelets 12 2001 74 82
27. C. Urbich, E. Dernbach, A. Aicher, A.M. Zeiher, and S. Dimmeler CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species Circulation 106 2002 981 986
28. V. Henn, J.R. Slupsky, M. Grafe, I. Anagnostopoulos, R. Forster, and G. Muller-Berghaus CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Nature 391 1998 591 594
29. J.R. Slupsky, M. Kalbas, A. Willuweit, V. Henn, R.A. Kroczek, and G. Muller-Berghaus Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40 Thromb Haemost 80 1998 1008 1014
30. K. Dimitriadis, C. Tsioufis, M. Selima, P. Missovoulos, P. Pavlidis, and D. Tousoulis Graded association between C-reactive protein, adiponectin and arterial stiffness in essential hypertensive subjects: an integrated approach to atherosclerosis Eur Heart J 28 2007 483
31. J. Loscalzo Oxidant stress: a key determinant of atherothrombosis Biochem Soc Trans 31 2003 1059 1061
32. S.S. Brar, J. ten Berg, R. Marcucci, M.J. Price, M. Valgimigli, and H.S. Kim Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data J Am Coll Cardiol 58 2011 1945 1954
33. G. Patti, A. Nusca, F. Mangiacapra, L. Gatto, A. D'Ambrosio, and G. Di Sciascio Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study J Am Coll Cardiol 52 2008 1128 1133
34. G. Range, K. Yayehd, L. Belle, C. Thuaire, P. Richard, and P. Cazaux Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY) Arch Cardiovasc Dis 107 2014 225 235